Security record · archived quarter
TSHA
Taysha Gene Therapies, Inc. · Healthcare · Biotechnology
6Tracked holders
0Δ holders
7.50MShares held
$15.08MReported value
+2New positions
−2Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +30.0% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +6 | 146.63M | $997.83M | +12 | −5 |
| Q1 2026 | 81 | -9 | 130.93M | $584.01M | +4 | −14 |
| Q4 2025 | 90 | 0 | 135.71M | $746.41M | +2 | −1 |
| Q3 2025 | 18 | -1 | 108.64M | $355.25M | — | −1 |
| Q2 2025 | 16 | +5 | 65.80M | $152.01M | +5 | — |
| Q1 2025 | 8 | -4 | 14.26M | $19.83M | +1 | −5 |
| Q4 2024 | 12 | +5 | 19.11M | $33.06M | +5 | — |
| Q3 2024 | 6 | 0 | 7.50M | $15.08M | +2 | −2 |
| Q2 2024 | 6 | — | 5.37M | $12.04M | — | — |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 3.56M | +23.7% | $7.16M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 3.56M | +23.7% | $7.16M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 2.86M | +6004.0% | $5.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 2.86M | +6004.0% | $5.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Marshall Wace ✦ | 486.03K | -38.2% | $976,911 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 463.19K | New | $931,016 | 0.0% | New | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 463.19K | New | $931,016 | 0.0% | New | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 69.47K | New | $139,637 | 0.0% | New | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 69.47K | New | $139,637 | 0.0% | New | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 59.72K | -95.3% | $121,000 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Wellington Management | $931,016 | 0.0% |
| Wellington Management | $931,016 | 0.0% |
| AQR Capital Management | $139,637 | 0.0% |
| AQR Capital Management | $139,637 | 0.0% |
Exited
| Millennium Management | $763,222 | was 0.0% |
| Renaissance Technologies | $92,064 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 190 holders, 265.00M shares, $1.21B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API